Let me know if you are here in Boston for the AF Symposium! Can share our capabilities across #RepSignal and Consulting, and give you hot restaurant tips!
We are excited to announce that the FARAPULSE™ Pulsed Field Ablation System is now FDA approved! Purposely built, FARAPULSE™ offers tissue selective cardiac #ablation for the treatment of PAF which minimizes thermal risk. See the FARAPULSE™ difference today: https://lnkd.in/gcRvyj9D Safety info: https://bit.ly/47VaqXO #PulsedFieldAblation
⏳ Accelerate Diagnostics gets FDA nod for Accelerate Arc system and BC kit The Accelerate Arc system and BC kit work as an automated positive blood culture sample preparation platform to fight against Sepsis and Antimicrobial Resistance (AMR). The platform is intended for use with Bruker’s MALDI Biotyper CA System (MBT-CA System) and MBT-CA Sepsityper software extension. Accelerate Arc system has a simple workflow that automates positive blood culture sample preparation for direct downstream microbial identification (ID) leveraging Bruker’s MBT-CA system. Read more online: https://lnkd.in/ebhK_KV8 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing
Filter Technologies Applied in IV Infusion https://wix.to/L2c4UB3
🔬 Explore the Power of Hemolysis Testing with NAMSA! 💉 Discover our recent blog post highlighting the Mechanical Hemolysis Assay performed at our Minneapolis lab. This vital in-vitro test, based on ASTM F1830 and F1841 guidelines, assesses the hemolytic potential of blood-contacting test articles compared to predicate devices. 👩🔬Learn how this adaptable test can benefit various device types and why it's FDA-recommended for assessing blood-contacting devices. Read the full article here 👉 https://lnkd.in/ea3XqGsX #HemolysisTesting #MedicalDevices #FDARecommended #NAMSAKnows
Vice President, Worldwide Respiratory Oscillometry (FOT) Products Business Development - MGC Diagnostics
...and here is how to briefly present a FIRST, the first mini-oscillometer, a revolutionary diagnostic device !... in French... ..MGC Diagnostics International, MGC Diagnostics, Restech - Respiratory Technology
Experienced and highly skilled physiotherapist assisting patients with physical difficulties resulting from illnesses, injuries, or aging.
Help me Improve this Prompt Share your Feedback here (takes only 1m): https://qr.ae/psvE3n 🌟 Curious about the best Viagra tablets brand? Look no further! 💊 Let's dive into the top contender in the market. 🚀 Join the conversation and share your thoughts! 💬 Renowned for efficacy and safety. Trusted by millions worldwide. Premium quality assurance. Expertly crafted formulations. What's your go-to brand for Viagra tablets? Share below! 👇 #Healthcare #Pharmaceuticals #Wellness #Viagra #HealthTech #Medicine #MensHealth #Innovation #Quality #HealthAndWellness
An accurate record of the maxillomandibular relationship is essential to articulating casts for appropriate diagnostics, laboratory work, and treatment for #dentalrestorations. This study from the latest issue of #theJPD compares the accuracy of #maximalintercuspation records made from common bite registration materials and #dentaltechniques: https://lnkd.in/gFj4yCCR
It's always good to hear how our CEFALY customers have found relief from their migraine symptoms CEFALY is a medical device for the treatment of migraine that uses external trigeminal nerve stimulation (eTNS) technology. CEFALY transmits a precise electrical impulse to the trigeminal nerve through an adhesive electrode worn on the forehead. The trigeminal nerve is the main pain pathway involved in migraine. CEFALY stimulates the trigeminal nerve and makes it less sensitive which results in a reduction in the frequency and severity of migraine attacks over time. ✅ Medication free approach ✅ Can be used alongside existing treatments ✅ Does not contribute to medication overuse headache ✅ Clinically proven treatment ✅ FDA - cleared & CE Marked Find out if CEFALY is the right migraine treatment for you ⤵️ https://buff.ly/43dD450 #migraine #migrainetreatment #migrainerelief #cefaly
The WSJ misunderstands the three tenets of Theranos' dream, namely 1) 200+ blood tests 2) from a fingerstick, and 3) for under the reimbursement cost of regular tests. Basically, they were promising comprehensive, easy and low cost blood testing. Finger-stick testing by itself won't provide enough value: -Some analytes are susceptible to lysis resulting from milking the finger or are in too low concentrations. -Cell counting and general chemistries require different anti-coagulants, so are multiple finger-sticks needed? -Any volume of blood over say 50 microliters will require a trained technician to extract and the sample site will most likely need CLIA certification or the instrument will need a CLIA-waiver. -The cost per test and throughput limitation of a novel finger-stick analyzer approach will lead to little additional revenue or foot-traffic. -No killer application has been identified with the time sensitivity needed to justify the cost of installing a whole new system. -Most people have more nerves in their fingers than in their forearms making finger-stick testing more painful. And the number of people that have a hard time producing large volumes from a finger-stick is WAY higher than that for a venous blood draw. Theranos failed not because their minimally viable product was incorrect but because it was unachievable. The fraud was merely the manifestation of their deeply held delusion. Many still believe that there exists a more minimally viable product within reach. Best of luck.
Have you heard about the IN.PACCT AV Drug Coated Balloon? This #WatchWednesday, watch our latest Healthline webinar to learn more about this game-changer in vascular access: bit.ly/3Tb3Bxd